Literature DB >> 3503870

Mimickry in osteogenic sarcoma. Clinical considerations and report of 2 cases.

F Vigliani1, E Campailla.   

Abstract

The authors report two cases of osteogenic sarcoma which presented under the false diagnosis of aneurysmal bone cyst and benign fibrous histiocytoma respectively. This mimickry is discussed: a) It is certainly more common than would appear from the literature, particularly in the case of aneurysmal bone cyst; b) this mimickry applies particularly to the lytic type of osteosarcoma; c) the adjective telangiectatic which is often used to describe malignant bone aneurysms is equivocal; d) immature forms of osteogenic sarcoma all possess a common factor with regard to onset, course and outcome of the disease; e) microscopic anaplastic elements may not always be observed in these imitations; f) clinical examination may often achieve or at least get closer to a true diagnosis of the disease: it is necessary to be aware of the existence of mimetic forms of osteogenic sarcoma and carefully evaluate all the available information; g) surgery should be delayed where clinical doubt exists and the histological report is negative. Such a delay may allow the tumour to reveal its true nature so that the surgeon and oncologist can select the correct treatment.

Entities:  

Mesh:

Year:  1987        PMID: 3503870

Source DB:  PubMed          Journal:  Ital J Orthop Traumatol        ISSN: 0390-5489


  2 in total

1.  High malignant surface osteosarcoma arising at the site of a previously treated aneurysmal bone cyst.

Authors:  P Wuisman; A Roessner; S Blasius; J Grünert; T Vestering; W Winkelmann
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

2.  Metastatic potential of an aneurysmal bone cyst.

Authors:  Addy C M van de Luijtgaarden; Rene P H Veth; Piet J Slootweg; Pauline M Wijers-Koster; Leo J Schultze Kool; Judith V M G Bovee; Winette T A van der Graaf
Journal:  Virchows Arch       Date:  2009-10-17       Impact factor: 4.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.